Report Detail

Request for Sample of this report

Other Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2019

  • RnM2922251
    • |
  • 11 February, 2019
    • |
  • Global
    • |
  • 99 Pages
    • |
  • QYResearch
    • |
  • Other

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market is valued at 130 million US$ in 2018 is expected to reach 260 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2019-2025.
This report focuses on ICAD (Intracranial Atherosclerotic Disease) Pathology volume and value at global level, regional level and company level. From a global perspective, this report represents overall ICAD (Intracranial Atherosclerotic Disease) Pathology market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Stryker
Balt
TERUMO
MicroPort
Acandis
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
primarily split into
Stent
PTA Balloon

Segment by Application
Hospital
Clinic
Other


Table of Contents

    Executive Summary

      1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview

      • 1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
      • 1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
        • 1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 primarily split into
        • 1.2.3 Stent
        • 1.2.4 PTA Balloon
      • 1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
        • 1.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Region
        • 1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size
        • 1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2014-2025)
        • 1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production (2014-2025)

      2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Manufacturers

      • 2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites, Area Served, Product Types
      • 2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation and Trends
        • 2.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate
        • 2.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Regions

      • 3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Regions
      • 3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions (2014-2019)
      • 3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Production
        • 3.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate (2014-2019)
        • 3.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Production
        • 3.5.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate (2014-2019)
        • 3.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China ICAD (Intracranial Atherosclerotic Disease) Pathology Production (2014-2019)
        • 3.6.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate (2014-2019)
        • 3.6.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Production (2014-2019)
        • 3.7.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate (2014-2019)
        • 3.7.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Regions

      • 4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Regions
      • 4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2014-2019)
      • 4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2014-2019)
      • 4.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2014-2019)
      • 4.5 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2014-2019)

      5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price Trend by Type

      • 5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Type (2014-2019)
      • 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2014-2019)
      • 5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2014-2019)
      • 5.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth by Type (2014-2019)

      6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis by Applications

      • 6.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2014-2019)
      • 6.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in ICAD (Intracranial Atherosclerotic Disease) Pathology Business

      • 7.1 Stryker
        • 7.1.1 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites and Area Served
        • 7.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction, Application and Specification
        • 7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Balt
        • 7.2.1 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites and Area Served
        • 7.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction, Application and Specification
        • 7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 TERUMO
        • 7.3.1 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites and Area Served
        • 7.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction, Application and Specification
        • 7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 MicroPort
        • 7.4.1 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites and Area Served
        • 7.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction, Application and Specification
        • 7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Acandis
        • 7.5.1 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites and Area Served
        • 7.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction, Application and Specification
        • 7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Cost Analysis

      • 8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
      • 8.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
      • 9.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast

      • 11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue Forecast
        • 11.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price and Trend Forecast (2019-2025)
      • 11.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Forecast by Regions (2019-2025)
        • 11.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue Forecast (2019-2025)
        • 11.2.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue Forecast (2019-2025)
      • 11.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2019-2025)
        • 11.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2019-2025)
        • 11.3.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2019-2025)
        • 11.3.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2019-2025)
      • 11.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on ICAD (Intracranial Atherosclerotic Disease) Pathology . Industry analysis & Market Report on ICAD (Intracranial Atherosclerotic Disease) Pathology is a syndicated market report, published as Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2019. It is complete Research Study and Industry Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$2,900.00
        		$4,350.00
        		$5,800.00
        		2,320.00
        		3,480.00
        		4,640.00
        		2,786.90
        		4,180.35
        		5,573.80
        		442,598.00
        		663,897.00
        		885,196.00
        		253,431.00
        		380,146.50
        		506,862.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo